Search results
3 dni temu · The 7 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 34.14, with a low estimate of 12 and a high estimate of 110. The average target predicts an increase of 289.73% from the current stock price of 8.76.
3 dni temu · Analyst Recommendations on Vir Biotechnology, Inc. Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating. Jun. 06. MT. HC Wainwright Adjusts Vir Biotechnology Price Target to $110 From $85, Maintains Buy Rating. Feb. 14.
3 dni temu · VIR's current price target is $34.14. Learn why top analysts are making this stock forecast for Vir Biotechnology at MarketBeat.
5 dni temu · 8 Analysts. VIR Stock Overview. An immunology company, develops therapeutic products to treat and prevent serious infectious diseases. About the company. Rewards. Revenue is forecast to grow 23.94% per year. Risk Analysis. Earnings are forecast to decline by an average of 1.6% per year for the next 3 years.
5 dni temu · Get a real-time Vir Biotechnology, Inc. (VIR) stock price quote with breaking news, financials, statistics, charts and more.
5 dni temu · The average price target for VIR is $34.14, which is 275.17% higher than the current price. The consensus rating is "Buy".
9 cze 2024 · Jan 29. Price target decreased by 9.2% to US$29.75. Nov 15. Show all updates. Earnings and Revenue Growth Forecasts. Show more. Analyst Future Growth Forecasts. Earnings vs Savings Rate: VIR is forecast to remain unprofitable over the next 3 years. Earnings vs Market: VIR is forecast to remain unprofitable over the next 3 years.
